The DOI matches its Crossref record; 167 of the 167 references it cites were found in a registry or an index.
Metalloproteinases and their inhibitors in tumor angiogenesis
Open accessAbstract
Angiogenesis is the process by which new blood vessels are formed from preexisting vasculature. It is an essential feature of the female reproductive cycle, embryonic development and wound repair. Angiogenesis has also been identified as a causal or contributing factor in several pathologies, including cancer, where it is a rate‐limiting step during tumor progression. Matrix metalloproteinases (MMPs) are a family of soluble and membrane‐anchored proteolytic enzymes that can degrade components of the extracellular matrix (ECM) as well as a growing number of modulators of cell function. Several of the MMPs, in particular the gelatinases and membrane‐type 1 MMP (MT1‐MMP), have been linked to angiogenesis. Potential roles for these proteases during the angiogenic process include degradation of the basement membrane and perivascular ECM components, unmasking of cryptic biologically relevant sites in ECM components, modulation of angiogenic factors and production of endogenous angiogenic inhibitors. This review brings together what is currently known about the functions of the MMPs and the closely related ADAM (a d isintegrin a nd m etalloproteinase domain) and ADAMTS (a d isintegrin a nd m etalloproteinase with t hrombo s pondin motifs) families in angiogenesis and considers how this information might be useful in manipulation of the angiogenic process, with a view to constraining tumor progression. © 2005 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Angiogenesis in cancer and other diseases
Carmeliet, P., & Jain, R. K. (2000) · Nature · doi:10.1038/35025220 · Cited by 9,070
Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
Hanahan, D., & Folkman, J. (1996) · Cell · doi:10.1016/s0092-8674(00)80108-7 · Cited by 6,885
New functions for the matrix metalloproteinases in cancer progression
Egeblad, M., & Werb, Z. (2002) · Nature Reviews Cancer · doi:10.1038/nrc745 · Cited by 6,108
Endostatin: an endogenous inhibitor of angiogenesis and tumor growth
O'Reilly, M. S., Boehm, T., Shing, Y., Fukai, N., Vasios, G., Lane, W. S., Flynn, E., Birkhead, J. R., Olsen, B. R., & Folkman, J. (1997) · Cell · doi:10.1016/s0092-8674(00)81848-6 · Cited by 4,486
Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis
Bergers, G., Brekken, R., McMahon, G., Vu, T. H., Itoh, T., Tamaki, K., Tanzawa, K., Thorpe, P., Itohara, S., Werb, Z., et al. (2000) · Nature Cell Biology · doi:10.1038/35036374 · Cited by 2,797
Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations
Coussens, L. M., Fingleton, B., & Matrisian, L. M. (2002) · Science · doi:10.1126/science.1067100 · Cited by 2,761
A matrix metalloproteinase expressed on the surface of invasive tumour cells
Sato, H., Takino, T., Okada, Y., Cao, J., Shinagawa, A., Yamamoto, E., & Seiki, M. (1994) · Nature · doi:10.1038/370061a0 · Cited by 2,551
Integrin αvβ3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels
Brooks, P. C., Montgomery, A. M. P., Rosenfeld, M., Reisfeld, R. A., Hu, T., Klier, G., & Cheresh, D. A. (1994) · Cell · doi:10.1016/0092-8674(94)90007-8 · Cited by 2,262
Yu, Q., & Stamenkovic, I. (2000) · PubMed · Cited by 1,995
Willett, C. G., Boucher, Y., di Tomaso, E., Duda, D. G., Munn, L. L., Tong, R. T., Chung, D. C., Sahani, D. V., Kalva, S. P., Kozin, S. V., et al. (2004) · Nature Medicine · doi:10.1038/nm988 · Cited by 1,966
Tissue inhibitors of metalloproteinases: evolution, structure and function
Brew, K., Dinakarpandian, D., & Nagase, H. (2000) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/s0167-4838(99)00279-4 · Cited by 1,908
Lyden, D., Hattori, K., Dias, S., Costa, C., Blaikie, P., Butros, L., Chadburn, A., Heissig, B., Marks, W., Witte, L., et al. (2001) · Nature Medicine · doi:10.1038/nm1101-1194 · Cited by 1,860
Yu, Q., & Stamenkovic, I. (2000) · Genes & Development · doi:10.1101/gad.14.2.163 · Cited by 1,754
Heissig, B., Hattori, K., Dias, S., Friedrich, M., Ferris, B., Hackett, N. R., Crystal, R. G., Besmer, P., Lyden, D., Moore, M. A. S., et al. (2002) · Cell · doi:10.1016/s0092-8674(02)00754-7 · Cited by 1,751
Vu, T. H., Shipley, J. M., Bergers, G., Berger, J. E., Helms, J. A., Hanahan, D., Shapiro, S. D., Senior, R. M., & Werb, Z. (1998) · Cell · doi:10.1016/s0092-8674(00)81169-1 · Cited by 1,750
Brooks, P. C., Strömblad, S., Sanders, L. C., von Schalscha, T. L., Aimes, R. T., Stetler-Stevenson, W. G., Quigley, J. P., & Cheresh, D. A. (1996) · Cell · doi:10.1016/s0092-8674(00)81235-0 · Cited by 1,552
The anti-angiogenic basis of metronomic chemotherapy
Kerbel, R. S., & Kamen, B. A. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1369 · Cited by 1,397
Definition of Two Angiogenic Pathways by Distinct α v Integrins
Friedlander, M., Brooks, P. C., Shaffer, R. W., Kincaid, C. M., Varner, J. A., & Cheresh, D. A. (1995) · Science · doi:10.1126/science.270.5241.1500 · Cited by 1,321
Holmbeck, K., Bianco, P., Caterina, J., Yamada, S., Kromer, M., Kuznetsov, S. A., Mankani, M., Gehron Robey, P., Poole, A. R., Pidoux, I., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80064-1 · Cited by 1,298
Angiostatin induces and sustains dormancy of human primary tumors in mice
O'Reilly, M. S., Holmgren, L., Chen, C., & Folkman, J. (1996) · Nature Medicine · doi:10.1038/nm0696-689 · Cited by 1,184
Metalloproteinase inhibitors: biological actions and therapeutic opportunities
Baker, A. H., Edwards, D. R., & Murphy, G. (2002) · Journal of Cell Science · doi:10.1242/jcs.00063 · Cited by 1,179
Self-citationThe ADAMs family of metalloproteases: multidomain proteins with multiple functions
Seals, D. F., & Courtneidge, S. A. (2003) · Genes & Development · doi:10.1101/gad.1039703 · Cited by 1,059
Effects of Angiogenesis Inhibitors on Multistage Carcinogenesis in Mice
Bergers, G., Javaherian, K., Lo, K.-M., Folkman, J., & Hanahan, D. (1999) · Science · doi:10.1126/science.284.5415.808 · Cited by 988
Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands
Sahin, U., Weskamp, G., Kelly, K., Zhou, H.-M., Higashiyama, S., Peschon, J., Hartmann, D., Saftig, P., & Blobel, C. P. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200307137 · Cited by 979
Reduced angiogenesis and tumor progression in gelatinase A-deficient mice.
Itoh, T., Tanioka, M., Yoshida, H., Yoshioka, T., Nishimoto, H., & Itohara, S. (1998) · PubMed · Cited by 875
Vasculogenic mimicry and tumour-cell plasticity: lessons from melanoma
Hendrix, M. J. C., Seftor, E. A., Hess, A. R., & Seftor, R. E. B. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1092 · Cited by 824
PORTER, S., CLARK, I. M., KEVORKIAN, L., & EDWARDS, D. R. (2005) · Biochemical Journal · doi:10.1042/bj20040424 · Cited by 779
Self-citationRole of the Matrix Metalloproteinase and Plasminogen Activator–Plasmin Systems in Angiogenesis
Pepper, M. S. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/hq0701.093685 · Cited by 777
Membrane-Type 1 Matrix Metalloproteinase Cleaves Cd44 and Promotes Cell Migration
Kajita, M., Itoh, Y., Chiba, T., Mori, H., Okada, A., Kinoh, H., & Seiki, M. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.153.5.893 · Cited by 746
Holash, J., Wiegand, S. J., & Yancopoulos, G. D. (1999) · Oncogene · doi:10.1038/sj.onc.1203035 · Cited by 744
Oh, J., Takahashi, R., Kondo, S., Mizoguchi, A., Adachi, E., Sasahara, R. M., Nishimura, S., Imamura, Y., Kitayama, H., Alexander, D. B., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00597-9 · Cited by 728
Matrix Metalloproteinases Regulate Neovascularization by Acting as Pericellular Fibrinolysins
Hiraoka, N., Allen, E., Apel, I. J., Gyetko, M. R., & Weiss, S. J. (1998) · Cell · doi:10.1016/s0092-8674(00)81768-7 · Cited by 712
Zhou, Z., Apte, S. S., Soininen, R., Cao, R., Baaklini, G. Y., Rauser, R. W., Wang, J., Cao, Y., & Tryggvason, K. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.060037197 · Cited by 666
Protease degradomics: A new challenge for proteomics
López-Otín, C., & Overall, C. M. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm858 · Cited by 664
Qi, J. H., Ebrahem, Q., Moore, N., Murphy, G., Claesson-Welsh, L., Bond, M., Baker, A., & Anand-Apte, B. (2003) · Nature Medicine · doi:10.1038/nm846 · Cited by 658
Brooks, P. C., Silletti, S., von Schalscha, T. L., Friedlander, M., & Cheresh, D. A. (1998) · Cell · doi:10.1016/s0092-8674(00)80931-9 · Cited by 623
TNF‐α converting enzyme (TACE) is inhibited by TIMP‐3
Amour, A., Slocombe, P. M., Webster, A., Butler, M., Knight, C. G., Smith, B. J., Stephens, P. E., Shelley, C., Hutton, M., Knäuper, V., et al. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)01031-x · Cited by 609
Taraboletti, G., D'Ascenzo, S., Borsotti, P., Giavazzi, R., Pavan, A., & Dolo, V. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64887-0 · Cited by 588
The ADAM gene family: surface proteins with adhesion and protease activity
Primakoff, P., & Myles, D. G. (2000) · Trends in Genetics · doi:10.1016/s0168-9525(99)01926-5 · Cited by 582
Will, H., Atkinson, S. J., Butler, G. S., Smith, B., & Murphy, G. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.29.17119 · Cited by 569
Tumor targeting with a selective gelatinase inhibitor
Koivunen, E., Arap, W., Valtanen, H., Rainisalo, A., Medina, O. P., Heikkilä, P., Kantor, C., Gahmberg, C. G., Salo, T., Konttinen, Y. T., et al. (1999) · Nature Biotechnology · doi:10.1038/11703 · Cited by 567
Hamano, Y., Zeisberg, M., Sugimoto, H., Lively, J. C., Maeshima, Y., Yang, C., Hynes, R. O., Werb, Z., Sudhakar, A., & Kalluri, R. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00133-8 · Cited by 559
TIMP-3 Is a Potent Inhibitor of Aggrecanase 1 (ADAM-TS4) and Aggrecanase 2 (ADAM-TS5)
Kashiwagi, M., Tortorella, M., Nagase, H., & Brew, K. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c000848200 · Cited by 509
TIMP-2 Mediated Inhibition of Angiogenesis
Seo, D.-W., Li, H., Guedez, L., Wingfield, P. T., Diaz, T., Salloum, R., Wei, B.-Y., & Stetler-Stevenson, W. G. (2003) · Cell · doi:10.1016/s0092-8674(03)00551-8 · Cited by 508
Takahashi, C., Sheng, Z., Horan, T. P., Kitayama, H., Maki, M., Hitomi, K., Kitaura, Y., Takai, S., Sasahara, R. M., Horimoto, A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.22.13221 · Cited by 492
Sudhakar, A., Sugimoto, H., Yang, C., Lively, J., Zeisberg, M., & Kalluri, R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0730882100 · Cited by 488
Leco, K. J., Khokha, R., Pavloff, N., Hawkes, S. P., & Edwards, D. R. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37115-6 · Cited by 480
Self-citationCanstatin, a Novel Matrix-derived Inhibitor of Angiogenesis and Tumor Growth
Kamphaus, G. D., Colorado, P. C., Panka, D. J., Hopfer, H., Ramchandran, R., Torre, A., Maeshima, Y., Mier, J. W., Sukhatme, V. P., & Kalluri, R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.2.1209 · Cited by 475
Rodríguez-Manzaneque, J. C., Lane, T. F., Ortega, M. A., Hynes, R. O., Lawler, J., & Iruela-Arispe, M. L. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.171460498 · Cited by 473
Takino, T., Sato, H., Shinagawa, A., & Seiki, M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.39.23013 · Cited by 471
Yu, W.-H., Woessner, J. F., McNeish, J. D., & Stamenkovic, I. (2002) · Genes & Development · doi:10.1101/gad.925702 · Cited by 471
Secreted cathepsin L generates endostatin from collagen XVIII
Felbor, U. (2000) · The EMBO Journal · doi:10.1093/emboj/19.6.1187 · Cited by 469
Hendrix, M. J. C., Seftor, E. A., Meltzer, P. S., Gardner, L. M. G., Hess, A. R., Kirschmann, D. A., Schatteman, G. C., & Seftor, R. E. B. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.131209798 · Cited by 456
Matrix Metalloproteinases Generate Angiostatin: Effects on Neovascularization
Cornelius, L. A., Nehring, L. C., Harding, E., Bolanowski, M., Welgus, H. G., Kobayashi, D. K., Pierce, R. A., & Shapiro, S. D. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.12.6845 · Cited by 444
Tumstatin, an Endothelial Cell-Specific Inhibitor of Protein Synthesis
Maeshima, Y., Sudhakar, A., Lively, J. C., Ueki, K., Kharbanda, S., Kahn, C. R., Sonenberg, N., Hynes, R. O., & Kalluri, R. (2002) · Science · doi:10.1126/science.1065298 · Cited by 438
Patterson, B. C., & Sang, Q. A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.46.28823 · Cited by 433
Vázquez, F., Hastings, G., Ortega, M.-A., Lane, T. F., Oikemus, S., Lombardo, M., & Iruela-Arispe, M. L. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.33.23349 · Cited by 426
Anti-angiogenic cues from vascular basement membrane collagen.
Colorado, P. C., Torre, A., Kamphaus, G. D., Maeshima, Y., Hopfer, H., Takahashi, K., Volk, R., Zamborsky, E. D., Herman, S., Sarkar, P. K., et al. (2000) · PubMed · Cited by 426
Sunnarborg, S. W., Hinkle, C. L., Stevenson, M., Russell, W. E., Raska, C. S., Peschon, J. J., Castner, B. J., Gerhart, M. J., Paxton, R. J., Black, R. A., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m112050200 · Cited by 413
Cleavage of Syndecan-1 by Membrane Type Matrix Metalloproteinase-1 Stimulates Cell Migration
Endo, K., Takino, T., Miyamori, H., Kinsen, H., Yoshizaki, T., Furukawa, M., & Sato, H. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306736200 · Cited by 410
The in vitro activity of ADAM‐10 is inhibited by TIMP‐1 and TIMP‐3
Amour, A., Knight, C. G., Webster, A., Slocombe, P. M., Stephens, P. E., Knäuper, V., Docherty, A. J. P., & Murphy, G. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01528-3 · Cited by 404
Pozzi, A., Moberg, P. E., Miles, L. A., Wagner, S., Soloway, P., & Gardner, H. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.040378497 · Cited by 395
Matrix metalloproteinase-2 is required for the switch to the angiogenic phenotype in a tumor model
Fang, J., Shing, Y., Wiederschain, D., Yan, L., Butterfield, C., Jackson, G., Harper, J., Tamvakopoulos, G., & Moses, M. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.8.3884 · Cited by 393
Strömblad, S., Becker, J. C., Yebra, M., Brooks, P. C., & Cheresh, D. A. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118808 · Cited by 383
Hanemaaijer, R., Koolwijk, P., le Clercq, L., de Vree, W. J. A., & van Hinsbergh, V. W. M. (1993) · Biochemical Journal · doi:10.1042/bj2960803 · Cited by 378
Generation and degradation of human endostatin proteins by various proteinases
Ferreras, M., Felbor, U., Lenhard, T., Olsen, B. R., & Delaissé, J.-M. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)02249-3 · Cited by 377
Seftor, R. E. B., Seftor, E. A., Koshikawa, N., Meltzer, P. S., Gardner, L. M. G., Bilban, M., Stetler‐Stevenson, W. G., Quaranta, V., & Hendrix, M. J. C. (2001) · PubMed · Cited by 369
Gutheil, J. C., Campbell, T. N., Pierce, P. R., Watkins, J. D., Huse, W. D., Bodkin, D., & Cheresh, D. A. (2000) · PubMed · Cited by 369
Davis, G. E., & Camarillo, C. W. (1996) · Experimental Cell Research · doi:10.1006/excr.1996.0109 · Cited by 354
Claesson-Welsh, L., Welsh, M., Ito, N., Anand-Apte, B., Soker, S., Zetter, B., O’Reilly, M., & Folkman, J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.10.5579 · Cited by 349
Huang, S. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.15.1134 · Cited by 349
Chun, T.-H., Sabeh, F., Ota, I., Murphy, H., McDonagh, K. T., Holmbeck, K., Birkedal-Hansen, H., Allen, E. D., & Weiss, S. J. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200405001 · Cited by 349
Targeting angiogenesis with a conjugate of HPMA copolymer and TNP-470
Satchi-Fainaro, R., Puder, M., Davies, J. W., Tran, H. T., Sampson, D. A., Greene, A. K., Corfas, G., & Folkman, J. (2004) · Nature Medicine · doi:10.1038/nm1002 · Cited by 345
Will, H., & Hinzmann, B. (1995) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1995.0602d.x · Cited by 336
Shindo, T., Kurihara, H., Kuno, K., Yokoyama, H., Wada, T., Kurihara, Y., Imai, T., Wang, Y., Ogata, M., Nishimatsu, H., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8635 · Cited by 329
Somerville, R. P. T., Longpre, J.-M., Jungers, K. A., Engle, J. M., Ross, M., Evanko, S., Wight, T. N., Leduc, R., & Apte, S. S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211009200 · Cited by 324
Captopril inhibits angiogenesis and slows the growth of experimental tumors in rats.
Volpert, O. V., Ward, W. F., Lingen, M. W., Chesler, L., Solt, D. B., Johnson, M. D., Molteni, A., Polverini, P. J., & Bouck, N. P. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118838 · Cited by 323
Kim, Y. M., Jang, J.-W., Lee, O., Yeon, J.-H., Choi, E.-Y., Kim, K., Lee, S., & Kwon, Y. (2000) · PubMed · Cited by 317
Schenk, S., Hintermann, E., Bilban, M., Koshikawa, N., Hojilla, C., Khokha, R., & Quaranta, V. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200208145 · Cited by 309
The role of tumor lymphangiogenesis in metastatic spread
STACKER, S. A., BALDWIN, M. E., & ACHEN, M. G. (2002) · The FASEB Journal · doi:10.1096/fj.01-0945rev · Cited by 296
The generation of endostatin is mediated by elastase.
Wen, W. X., Moses, M. A., Wiederschain, D., Arbiser, J. L., & Folkman, J. (1999) · PubMed · Cited by 285
Expression of matrix metalloproteinase 9 (96‐kd gelatinase B) in human rheumatoid arthritis
Ahrens, D., Koch, A. E., Pope, R. M., Stein‐Picarella, M., & Niedbala, M. J. (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780390919 · Cited by 284
Tozer, G. M., Prise, V. E., Wilson, J., Čemažar, M., Shan, S., Dewhirst, M. W., Barber, P. R., Vojnovic, B., & Chaplin, D. J. (2001) · PubMed · Cited by 283
Thrombospondins 1 and 2 function as inhibitors of angiogenesis
Armstrong, L. C., & Bornstein, P. (2003) · Matrix Biology · doi:10.1016/s0945-053x(03)00005-2 · Cited by 282
Lamoreaux, W. J., Fitzgerald, M. E. C., Reiner, A., Hasty, K. A., & Charles, S. T. (1998) · Microvascular Research · doi:10.1006/mvre.1997.2056 · Cited by 278
Cal, S., Obaya, A. J., Llamazares, M., Garabaya, C., Quesada, V., & López-Otı́n, C. (2002) · Gene · doi:10.1016/s0378-1119(01)00861-7 · Cited by 273
O'Reilly, M. S., Wiederschain, D., Stetler-Stevenson, W. G., Folkman, J., & Moses, M. A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.41.29568 · Cited by 272
Molecular Determinants of Ovarian Cancer Plasticity
Sood, A. K., Seftor, E. A., Fletcher, M. S., Gardner, L. M. G., Heidger, P. M., Buller, R. E., Seftor, R. E. B., & Hendrix, M. J. C. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64079-5 · Cited by 268
Identification and Characterization of the Fifth Membrane-type Matrix Metalloproteinase MT5-MMP
Pei, D. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.13.8925 · Cited by 267
ADAMTS1/METH1 Inhibits Endothelial Cell Proliferation by Direct Binding and Sequestration of VEGF165
Luque, A., Carpizo, D. R., & Iruela-Arispe, M. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212964200 · Cited by 263
Sounni, N. E., Devy, L., Hajitou, A., Frankenne, F., Munaut, C., Gilles, C., Deroanne, C., Thompson, E. W., Foidart, J. M., & Noel, A. (2002) · The FASEB Journal · doi:10.1096/fj.01-0790com · Cited by 260
Uekita, T., Itoh, Y., Yana, I., Ohno, H., & Seiki, M. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.200108112 · Cited by 252
Inhibition of angiogenesis by tissue inhibitor of metalloproteinase-3.
Anand‐Apte, B., Pepper, M. S., Voest, E. E., Montesano, R., Olsen, B. R., Murphy, G., Apte, S., & Zetter, B. R. (1997) · PubMed · Cited by 251
Leco, K. J., Waterhouse, P. D., Sanchez, O. H., Gowing, K. L. M., Poole, A. R., Wakeham, A. C., Mak, T. W., & Khokha, R. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12067 · Cited by 246
Lafleur, M. A., Handsley, M. M., Knäuper, V., Murphy, G., & Edwards, D. R. (2002) · Journal of Cell Science · doi:10.1242/jcs.115.17.3427 · Cited by 244
Self-citationSHALINSKY, D. R., BREKKEN, J., ZOU, H., MCDERMOTT, C. D., FORSYTH, P., EDWARDS, D., MARGOSIAK, S., BENDER, S., TRUITT, G., WOOD, A., et al. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb07689.x · Cited by 239
Self-citationBelkin, A. M., Akimov, S. S., Zaritskaya, L. S., Ratnikov, B. I., Deryugina, E. I., & Strongin, A. Y. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010135200 · Cited by 233
Identification of the Anti-angiogenic Site within Vascular Basement Membrane-derived Tumstatin
Maeshima, Y., Manfredi, M., Reimer, C., Holthaus, K. A., Hopfer, H., Chandamuri, B. R., Kharbanda, S., & Kalluri, R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007764200 · Cited by 230
Leco, K. J., Waterhouse, P., Sanchez, O. H., Gowing, K. L. M., Poole, A. R., Wakeham, A., Mak, T. W., & Khokha, R. (2001) · Journal of Clinical Investigation · doi:10.1172/jci200112067 · Cited by 230
Davis, G. E., Allen, K. A. P., Salazar, R., & Maxwell, S. A. (2001) · Journal of Cell Science · doi:10.1242/jcs.114.5.917 · Cited by 228
Interstitial Collagenase Is Required for Angiogenesis in Vitro
Fisher, C., Gilbertson-Beadling, S., Powers, E. A., Petzold, G., Poorman, R., & Mitchell, M. A. (1994) · Developmental Biology · doi:10.1006/dbio.1994.1104 · Cited by 227
Preclinical and Clinical Studies of MMP Inhibitors in Cancer
DRUMMOND, A. H., BECKETT, P., BROWN, P. D., BONE, E. A., DAVIDSON, A. H., GALLOWAY, W. A., GEARING, A. J. H., HUXLEY, P., LABER, D., MCCOURT, M., et al. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb07688.x · Cited by 219
Chantrain, C. F., Shimada, H., Jodele, S., Groshen, S., Ye, W., Shalinsky, D. R., Werb, Z., Coussens, L. M., & DeClerck, Y. A. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-0160 · Cited by 218
Deryugina, E. I., Ratnikov, B. I., Postnova, T. I., Rozanov, D. V., & Strongin, A. Y. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110269200 · Cited by 212
Membrane type-matrix metalloproteinases (MT-MMP)
Zucker, S., Pei, D., Cao, J., & Lopez-Otin, C. (2003) · Current Topics in Developmental Biology · doi:10.1016/s0070-2153(03)54004-2 · Cited by 200
Taylor, K. L., Henderson, A. M., & Hughes, C. C. W. (2002) · Microvascular Research · doi:10.1006/mvre.2002.2443 · Cited by 199
Taga, T., Suzuki, A., Gonzalez‐Gomez, I., Gilles, F. H., Stins, M., Shimada, H., Barsky, L., Weinberg, K. I., & Laug, W. E. (2002) · International Journal of Cancer · doi:10.1002/ijc.10265 · Cited by 198
Expression analysis of the entire MMP and TIMP gene families during mouse tissue development
Nuttall, R. K., Sampieri, C. L., Pennington, C. J., Gill, S. E., Schultz, G. A., & Edwards, D. R. (2004) · FEBS Letters · doi:10.1016/s0014-5793(04)00281-9 · Cited by 194
Self-citationPotential Role for ADAM15 in Pathological Neovascularization in Mice
Horiuchi, K., Weskamp, G., Lum, L., Hammes, H.-P., Cai, H., Brodie, T. A., Ludwig, T., Chiusaroli, R., Baron, R., Preissner, K. T., et al. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.16.5614-5624.2003 · Cited by 189
Vasculogenic Mimicry: How Convincing, How Novel, and How Significant?
McDonald, D. M., Munn, L., & Jain, R. K. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64740-2 · Cited by 187
Generation of an Angiostatin-like Fragment from Plasminogen by Stromelysin-1 (MMP-3)
Lijnen, H. R., Ugwu, F., Bini, A., & Collen, D. (1998) · Biochemistry · doi:10.1021/bi9731798 · Cited by 185
Nuttall, R. K., Pennington, C. J., Taplin, J., Wheal, A., Yong, V. W., Forsyth, P. A., & Edwards, D. R. (2003) · PubMed · Cited by 175
Self-citationAhonen, M., Poukkula, M., Baker, A. H., Kashiwagi, M., Nagase, H., Eriksson, J. E., & Kähäri, V.-M. (2003) · Oncogene · doi:10.1038/sj.onc.1206292 · Cited by 173
Wang, M., Liu, Y. E., Greene, J., Sheng, S., Fuchs, A., Rosen, E. M., & Shi, Y. E. (1997) · Oncogene · doi:10.1038/sj.onc.1201245 · Cited by 169
Itoh, Y., Kajita, M., Kinoh, H., Mori, H., Okada, A., & Seiki, M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.48.34260 · Cited by 168
Vasculogenic mimicry and pseudo‐comedo formation in breast cancer
Shirakawa, K., Wakasugi, H., Heike, Y., Watanabe, I., Yamada, S., Saito, K., & Konishi, F. (2002) · International Journal of Cancer · doi:10.1002/ijc.10423 · Cited by 167
Deryugina, E. I., Soroceanu, L., & Strongin, A. Y. (2002) · PubMed · Cited by 158
Low plasma levels of matrix metalloproteinase 9 permit increased tumor angiogenesis
Pozzi, A., LeVine, W. F., & Gardner, H. (2002) · Oncogene · doi:10.1038/sj.onc.1205045 · Cited by 154
Ratnikov, B. I., Rozanov, D. V., Postnova, T. I., Baciu, P. G., Zhang, H., DiScipio, R. G., Chestukhina, G. G., Smith, J. W., Deryugina, E. I., & Strongin, A. Y. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109580200 · Cited by 152
The enzymatic activity of ADAM8 and ADAM9 is not regulated by TIMPs
Amour, A., Knight, C. G., English, W., Webster, A., Slocombe, P. M., Knäuper, V., Docherty, A., Becherer, J. D., Blobel, C., & Murphy, G. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)03047-8 · Cited by 151
Matrilysin cleavage of corneal collagen type XVIII NC1 domain and generation of a 28-kDa fragment.
Lin, H., Chang, J., Jain, S. K., Gabison, E. E., Kure, T., Kato, T., Fukai, N., & Azar, D. T. (2001) · PubMed · Cited by 150
Growth factor–induced angiogenesis in vivo requires specific cleavage of fibrillar type I collagen
Seandel, M., Noack–Kunnmann, K., Zhu, D., Aimes, R. T., & Quigley, J. P. (2001) · Blood · doi:10.1182/blood.v97.8.2323 · Cited by 142
Kojima, S., Itoh, Y., Matsumoto, S., Masuho, Y., & Seiki, M. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01919-0 · Cited by 138
Diminished corneal angiogenesis in gelatinase A‐deficient mice
Kato, T., Kure, T., Chang, J.-H., Gabison, E. E., Itoh, T., Itohara, S., & Azar, D. T. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02897-6 · Cited by 134
Hangai, M., Kitaya, N., Xu, J., Chan, C. K.-C., Kim, J., Werb, Z., Ryan, S. J., & Brooks, P. C. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64418-5 · Cited by 132
BEEBE, J. S., Jani, J. P., Knauth, E. A., Goodwin, P., Higdon, C., Rossi, A. M., Emerson, E. O., Finkelstein, M. B., Floyd, E., Harriman, S. P., et al. (2003) · PubMed · Cited by 128
Hydroxamate-type matrix metalloproteinase inhibitor batimastat promotes liver metastasis.
Krüger, A., Soeltl, R., Sopov, I., Kopitz, C., Arlt, M., Magdolen, V., Harbeck, N., Gänsbacher, B., & Schmitt, M. (2001) · PubMed · Cited by 127
Gingras, D., Bousquet-Gagnon, N., Langlois, S., Lachambre, M., Annabi, B., & Béliveau, R. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02985-4 · Cited by 123
Matrix Metalloproteinase-9 Contributes to Choroidal Neovascularization
Lambert, V., Munaut, C., Jost, M., Noël, A., Werb, Z., Foidart, J., & Rakic, J. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64401-x · Cited by 120
Jiang, Y., Wang, M., Celiker, M., Liu, Y., Sang, Q., Goldberg, I. D., & Shi, Y. E. (2001) · PubMed · Cited by 119
Endostatin binds to the catalytic domain of matrix metalloproteinase‐2
Lee, S., Jang, J.-W., Kim, Y.-M., Lee, H. I., Jeon, J. Y., Kwon, Y., & Lee, S. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)02742-4 · Cited by 116
Guédez, L., McMarlin, A., Kingma, D. W., Bennett, T. A., Stetler‐Stevenson, M., & Stetler‐Stevenson, W. G. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64070-9 · Cited by 115
Inhibition of In Vitro Angiogenesis by Platelet Factor-4–Derived Peptides and Mechanism of Action
Jouan–Hureaux, V., Canron, X., Alemany, M., Caen, J., Quentin, G., Plouët, J., & Bikfalvi, A. (1999) · Blood · doi:10.1182/blood.v94.3.984.415k31_984_993 · Cited by 113
Fernández, C. A., Butterfield, C., Jackson, G., & Moses, M. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306176200 · Cited by 110
Ikenaka, Y., Yoshiji, H., Kuriyama, S., Yoshii, J., Noguchi, R., Tsujinoue, H., Yanase, K., Namisaki, T., Imazu, H., Masaki, T., et al. (2003) · International Journal of Cancer · doi:10.1002/ijc.11094 · Cited by 110
Koolwijk, P., Sidénius, N., Peters, E., Sier, C. F. M., Hanemaaijer, R., Blasi, F., & van Hinsbergh, V. W. M. (2001) · Blood · doi:10.1182/blood.v97.10.3123 · Cited by 109
Naglich, J. G., Jure‐Kunkel, M., Gupta, E., Fargnoli, J., Henderson, A. J., Lewin, A. C., Talbott, R. L., Baxter, A., Bird, J., Savopoulos, R., et al. (2001) · PubMed · Cited by 109
The role of the matrix metalloproteinases during in vitro vessel formation
Burbridge, M. F., Cogé, F., Galizzi, J., Boutin, J. A., West, D. C., & Tucker, G. C. (2002) · Angiogenesis · doi:10.1023/a:1023889805133 · Cited by 107
Lozonschi, L., Sunamura, M., Kobari, M., Egawa, S., Ding, L., & Matsuno, S. (1999) · PubMed · Cited by 107
Steitz, J., Br�ck, J., Steinbrink, K., Enk, A., Knop, J. X. F. R., & Tüting, T. (2000) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(20000401)86:1<15::aid-ijc3>3.0.co;2-b · Cited by 106
AdTIMP-2 Inhibits Tumor Growth, Angiogenesis, and Metastasis, and Prolongs Survival in Mice
Li, H., Lindenmeyer, F., Grenet, C., Opolon, P., Ménashi, S., Soria, C., Yeh, P., Perricaudet, M., & Lu, H. (2001) · Human Gene Therapy · doi:10.1089/104303401300042429 · Cited by 102
Spurbeck, W. W., Ng, C. Y., Strom, T. S., Vanin, E. F., & Davidoff, A. M. (2002) · Blood · doi:10.1182/blood.v100.9.3361 · Cited by 101
Majka, S. M., McGuire, P. G., & Das, A. (2002) · PubMed · Cited by 97
Hajitou, A., Sounni, N. E., Devy, L., Grignet, C., Lewalle, J.-M., Li, H., Deroanne, C., Lu, H., Colige, A., Nusgens, B., et al. (2001) · PubMed · Cited by 95
Gorrín-Rivas, M. J., Arii, S., Furutani, M., Mizumoto, M., Mori, A., Hanaki, K., Maeda, M., Furuyama, H., Kondo, Y., & Imamura, M. (2000) · PubMed · Cited by 88
Indraccolo, S., Gola, E., Rosato, A., Minuzzo, S. A., Habeler, W., Tisato, V., Roni, V., Esposito, G., Morini, M., Albini, A., et al. (2002) · Gene Therapy · doi:10.1038/sj.gt.3301703 · Cited by 83
Nakamura, E. S., Koizumi, K., Kobayashi, M., & Saiki, I. (2004) · Cancer Science · doi:10.1111/j.1349-7006.2004.tb03166.x · Cited by 80
Uekita, T., Gotoh, I., Kinoshita, T., Itoh, Y., Sato, H., Shiomi, T., Okada, Y., & Seiki, M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m309957200 · Cited by 79
Hepatocyte Growth Factor Enhances MMP Activity in Human Endothelial Cells
Wang, H., & Keiser, J. A. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2852 · Cited by 77
Seftor, R. E. B., Seftor, E. A., Kirschmann, D. A., & Hendrix, M. J. C. (2002) · PubMed · Cited by 74
Expression of Metalloproteinases and Their Inhibitors in Blood Vesselsin Human Endometrium1
Freitas, S., Méduri, G., Nestour, E. L., Bausero, P., & Perrot‐Applanat, M. (1999) · Biology of Reproduction · doi:10.1095/biolreprod61.4.1070 · Cited by 73
Troeberg, L., Tanaka, M., Wait, R., Shi, Y. E., Brew, K., & Nagase, H. (2002) · Biochemistry · doi:10.1021/bi026454l · Cited by 72
Ahonen, M., Ala‐aho, R., Baker, A. H., George, S. J., Grenman, R. A., Saarialho‐Kere, U., & Kähäri, V. (2002) · Molecular Therapy · doi:10.1006/mthe.2002.0606 · Cited by 71
Celiker, M., Wang, M., Atsidaftos, E., Liu, X., Liu, Y., Jiang, Y., Valderrama, E., Goldberg, I. D., & Shi, Y. E. (2001) · Oncogene · doi:10.1038/sj.onc.1204508 · Cited by 67
Vasculogenesis Plays a Role in the Growth of Ewing's Sarcoma in Vivo.
Bolontrade, M. F., Zhou, R., & Kleinerman, E. S. (2002) · PubMed · Cited by 66
Su, J.-M., Wei, Y.-Q., Tian, L., Zhao, X., Li, Y., He, Q.-M., Wang, Y., Lü, Y., Wu, Y., Liu, F., et al. (2003) · PubMed · Cited by 60
Neovastat—a novel antiangiogenic drug for cancer therapy
Gingras, D., Boivin, D., Deckers, C., Gendron, S. P., Barthomeuf, C., & Béliveau, R. (2003) · Anti-Cancer Drugs · doi:10.1097/00001813-200302000-00001 · Cited by 57
The antiangiogenic agent Neovastat (AE-941) induces endothelial cell apoptosis.
Boivin, D., Gendron, S. P., Beaulieu, É., Gingras, D., & Béliveau, R. (2002) · PubMed · Cited by 57
Matrix Metalloproteinases in Blood Vessel Development in Human Fetal Skin and in Cutaneous Tumors
Karelina, T. V., Goldberg, G. I., & Eisen, A. Z. (1995) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12321097 · Cited by 56
Nitric oxide regulates matrix metalloprotease-13 expression and activity in endothelium
Zaragoza, C., Balbín, M., López-Otín, C., & Lamas, S. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00224.x · Cited by 55
Perivascular Cells Regulate Endothelial Membrane Type-1 Matrix Metalloproteinase Activity
Lafleur, M. A., Forsyth, P. A., Atkinson, S. J., Murphy, G., & Edwards, D. R. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.4596 · Cited by 53
Self-citationHerbst, R. S., Hammond, L. A., Carbone, D. P., Tran, H. T., Holroyd, K. J., Desai, A. G., Williams, J. I., Bekele, B. N., Hait, H. I., Allgood, V., et al. (2003) · PubMed · Cited by 49
Takahashi, M., Fukami, S., Iwata, N., Inoue, K., Itohara, S., Itoh, H., Haraoka, J., & Saido, T. C. (2002) · Pharmacological Research · doi:10.1016/s1043-6618(02)00081-6 · Cited by 43
Chan, V. T., Zhang, D. N., Nagaravapu, U., Hultquist, K., Romero, L. I., & Herron, G. S. (1998) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.1998.00416.x · Cited by 39
Feldman, A. L., Stetler‐Stevenson, W. G., Costouros, N. G., Knezevic, V., Baibakov, G., Alexander, H. R., Lorang, D., Hewitt, S. M., Seo, D. W., Miller, M. S., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2929 · Cited by 36
Wagenaar-Miller, R. A., Hanley, G., Shattuck-Brandt, R. L., DuBois, R. N., Bell, R. L., Matrisian, L. M., & Morgan, D. W. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6600867 · Cited by 31
Cited by
The Roles of Matrix Metalloproteinases and Their Inhibitors in Human Diseases
Cabral-Pacheco, G. A., Garza-Veloz, I., Castruita-De la Rosa, C., Ramirez-Acuña, J. M., Perez-Romero, B. A., Guerrero-Rodriguez, J. F., Martinez-Avila, N., & Martinez-Fierro, M. L. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249739 · Cited by 1,820
Brew, K., & Nagase, H. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2010.01.003 · Cited by 1,381
Matrix metalloproteinases in the brain and blood–brain barrier: Versatile breakers and makers
Rempe, R. G., Hartz, A. M., & Bauer, B. (2016) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x16655551 · Cited by 721
Endothelial sprouting and angiogenesis: matrix metalloproteinases in the lead
van Hinsbergh, V. W. M., & Koolwijk, P. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvm102 · Cited by 420
Membrane-type matrix metalloproteinases: Their functions and regulations
Itoh, Y. (2015) · Matrix Biology · doi:10.1016/j.matbio.2015.03.004 · Cited by 401
Metadata
- Authors
- Handsley, M. M., & Edwards, D. R.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 2005-02-23
- Volume
- 115
- Issue
- 6
- Pages
- 849-860
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W1973857272
- Cited by
- 307
- References
- 167
- FWCI
- 11.52
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.